Preparation and Biopharmaceutical Evaluation of Novel Polymeric Nanoparticles Containing Etoposide for Targeting Cancer Cells

@article{Thiyagarajan2019PreparationAB,
  title={Preparation and Biopharmaceutical Evaluation of Novel Polymeric Nanoparticles Containing Etoposide for Targeting Cancer Cells},
  author={A. Thiyagarajan and Shanmugam Saravanabhavan and V. Thangarasu},
  journal={Turkish Journal of Pharmaceutical Sciences},
  year={2019},
  volume={16},
  pages={132 - 140}
}
  • A. Thiyagarajan, Shanmugam Saravanabhavan, V. Thangarasu
  • Published 2019
  • Chemistry, Medicine
  • Turkish Journal of Pharmaceutical Sciences
  • Objectives: Polymeric nanoparticles are a promising novel drug delivery system and have advantages in cancer therapy. Etoposide is an anticancer agent that is used in the treatment of a variety of malignancies. The aim of the present study was to prepare and evaluate novel polymeric nanoparticles containing etoposide. Materials and Methods: A 32 full factorial design was used to study the effect of Eudragit EPO and Pluronic F-68 on the characterization of nanoparticle suspensions. The polymeric… CONTINUE READING
    3 Citations

    References

    SHOWING 1-10 OF 29 REFERENCES
    Folate-targeted etoposide-encapsulated lipid nanospheres.
    • 15
    Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    • 205
    Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
    • 74
    Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
    • 160
    Lipid nanocapsules: a new platform for nanomedicine.
    • 367
    • PDF
    Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.
    • 93
    Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics
    • 76